Immuneai-CMV (Phase 1): Precision Phenotyping Reveals Heterogeneous CMV–GVHD Trade-Offs Following Allogeneic HCT

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Eman M. Elsabbagh, Augusto Dulanto Chiang, Mohammad K. Alexanderani

DOI: 10.1016/j.jtct.2025.12.800

Cited by: 1

Fields of Study & Subjects

Cytomegalovirus and herpesvirus research Immunodeficiency and Autoimmune Disorders Hematopoietic Stem Cell Transplantation